ACTAVIS MID ATLANTIC FDA Approval ANDA 087796

ANDA 087796

ACTAVIS MID ATLANTIC

FDA Drug Application

Application #087796

Application Sponsors

ANDA 087796ACTAVIS MID ATLANTIC

Marketing Status

Discontinued001

Application Products

001OINTMENT;TOPICAL1%0HYDROCORTISONEHYDROCORTISONE

FDA Submissions

ORIG1AP1982-10-13
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1986-06-12
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1986-06-12
LABELING; LabelingSUPPL6AP1993-05-17
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1989-07-26
LABELING; LabelingSUPPL8AP1992-03-04
LABELING; LabelingSUPPL9AP1994-02-09
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1995-02-24
MANUF (CMC); Manufacturing (CMC)SUPPL11AP1996-02-07
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1996-06-28
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1999-03-26
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2000-12-29
MANUF (CMC); Manufacturing (CMC)SUPPL15AP2001-04-26

Submissions Property Types

SUPPL1Null0
SUPPL4Null0
SUPPL5Null0
SUPPL7Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0

CDER Filings

ACTAVIS MID ATLANTIC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 87796
            [companyName] => ACTAVIS MID ATLANTIC
            [docInserts] => ["",""]
            [products] => [{"drugName":"HYDROCORTISONE","activeIngredients":"HYDROCORTISONE","strength":"1%","dosageForm":"OINTMENT;TOPICAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HYDROCORTISONE","submission":"HYDROCORTISONE","actionType":"1%","submissionClassification":"OINTMENT;TOPICAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.